Shantell Laketa Heiber

Array ( [id] => 4288785 [patent_doc_number] => 06183746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Immunogenic peptides from the HPV E7 protein' [patent_app_type] => 1 [patent_app_number] => 9/169425 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6328 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183746.pdf [firstpage_image] =>[orig_patent_app_number] => 169425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4401566 [patent_doc_number] => 06171592 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Equine rhinovirus 1 proteins' [patent_app_type] => 1 [patent_app_number] => 9/091219 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 30 [patent_no_of_words] => 10319 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171592.pdf [firstpage_image] =>[orig_patent_app_number] => 091219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126320 [patent_doc_number] => 06146641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Avian leukosis virus subgroup J envelope gene product for diagnosis and immunogenic composition' [patent_app_type] => 1 [patent_app_number] => 9/160065 [patent_app_country] => US [patent_app_date] => 1998-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8033 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146641.pdf [firstpage_image] =>[orig_patent_app_number] => 160065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4042442 [patent_doc_number] => 05968522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Immunogenic compositions and antibodies directed against human papillomavirus type 49 (HPV 49), type 50 (HPV 50), type 54 (HPV 54), and type 55 (HPV 55).' [patent_app_type] => 1 [patent_app_number] => 9/136425 [patent_app_country] => US [patent_app_date] => 1998-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7076 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968522.pdf [firstpage_image] =>[orig_patent_app_number] => 136425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4413922 [patent_doc_number] => 06193982 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120' [patent_app_type] => 1 [patent_app_number] => 9/136594 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 18856 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/193/06193982.pdf [firstpage_image] =>[orig_patent_app_number] => 136594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4210509 [patent_doc_number] => 06086918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Oral peptide pharmaceutical products' [patent_app_type] => 1 [patent_app_number] => 9/125500 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9726 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/086/06086918.pdf [firstpage_image] =>[orig_patent_app_number] => 125500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129567 [patent_doc_number] => 06146850 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Proteins encoding gelonin sequences' [patent_app_type] => 1 [patent_app_number] => 9/136389 [patent_app_country] => US [patent_app_date] => 1998-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 62730 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146850.pdf [firstpage_image] =>[orig_patent_app_number] => 136389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1499228 [patent_doc_number] => 06485728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-26 [patent_title] => 'Formalin-Inactivated human papillomavirus L1 protein vaccine' [patent_app_type] => B2 [patent_app_number] => 09/134377 [patent_app_country] => US [patent_app_date] => 1998-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 20016 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485728.pdf [firstpage_image] =>[orig_patent_app_number] => 09134377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416854 [patent_doc_number] => 06177082 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Cold-adapted equine influenza viruses' [patent_app_type] => 1 [patent_app_number] => 9/133921 [patent_app_country] => US [patent_app_date] => 1998-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15630 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177082.pdf [firstpage_image] =>[orig_patent_app_number] => 133921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4080034 [patent_doc_number] => 06162440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'EBNA2 peptides and methods of using same' [patent_app_type] => 1 [patent_app_number] => 9/133341 [patent_app_country] => US [patent_app_date] => 1998-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 12328 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162440.pdf [firstpage_image] =>[orig_patent_app_number] => 133341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494048 [patent_doc_number] => 06342383 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Cell lines and viral isolates associated with multiple sclerosis' [patent_app_type] => B1 [patent_app_number] => 09/133411 [patent_app_country] => US [patent_app_date] => 1998-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 17030 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342383.pdf [firstpage_image] =>[orig_patent_app_number] => 09133411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4245797 [patent_doc_number] => 06221646 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Materials and methods for simplified AAV production' [patent_app_type] => 1 [patent_app_number] => 9/127268 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7305 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221646.pdf [firstpage_image] =>[orig_patent_app_number] => 127268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324260 [patent_doc_number] => 06312689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 9/121781 [patent_app_country] => US [patent_app_date] => 1998-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 6 [patent_no_of_words] => 18439 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312689.pdf [firstpage_image] =>[orig_patent_app_number] => 121781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294244 [patent_doc_number] => 06180614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'DNA based vaccination of fish' [patent_app_type] => 1 [patent_app_number] => 9/115423 [patent_app_country] => US [patent_app_date] => 1998-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8686 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180614.pdf [firstpage_image] =>[orig_patent_app_number] => 115423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4377193 [patent_doc_number] => 06294176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species' [patent_app_type] => 1 [patent_app_number] => 9/113750 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 37411 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294176.pdf [firstpage_image] =>[orig_patent_app_number] => 113750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416830 [patent_doc_number] => 06177080 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy' [patent_app_type] => 1 [patent_app_number] => 9/112248 [patent_app_country] => US [patent_app_date] => 1998-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7523 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177080.pdf [firstpage_image] =>[orig_patent_app_number] => 112248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4229367 [patent_doc_number] => 06165471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents' [patent_app_type] => 1 [patent_app_number] => 9/109036 [patent_app_country] => US [patent_app_date] => 1998-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 12649 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165471.pdf [firstpage_image] =>[orig_patent_app_number] => 109036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150134 [patent_doc_number] => 06113879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Composition comprising methylphenidate and another drug' [patent_app_type] => 1 [patent_app_number] => 9/106870 [patent_app_country] => US [patent_app_date] => 1998-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2000 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113879.pdf [firstpage_image] =>[orig_patent_app_number] => 106870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234588 [patent_doc_number] => 06143548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Chromatographic purification of adeno-associated virus (AAV)' [patent_app_type] => 1 [patent_app_number] => 9/011828 [patent_app_country] => US [patent_app_date] => 1998-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12534 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143548.pdf [firstpage_image] =>[orig_patent_app_number] => 011828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150647 [patent_doc_number] => 06113913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Recombinant adenovirus' [patent_app_type] => 1 [patent_app_number] => 9/105515 [patent_app_country] => US [patent_app_date] => 1998-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6006 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113913.pdf [firstpage_image] =>[orig_patent_app_number] => 105515 [rel_patent_id] =>[rel_patent_doc_number] =>)